CoChat

CXCR4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses

Open access

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Abstract

It is well established that Ly6Chi monocytes develop from common monocyte progenitors (cMoPs) and reside in the bone marrow (BM) until they are mobilized into the circulation. In our study, we found that BM Ly6Chi monocytes are not a homogenous population, as current data would suggest. Using computational analysis approaches to interpret multidimensional datasets, we demonstrate that BM Ly6Chi monocytes consist of two distinct subpopulations (CXCR4hi and CXCR4lo subpopulations) in both mice and humans. Transcriptome studies and in vivo assays revealed functional differences between the two subpopulations. Notably, the CXCR4hi subset proliferates and is immobilized in the BM for the replenishment of functionally mature CXCR4lo monocytes. We propose that the CXCR4hi subset represents a transitional premonocyte population, and that this sequential step of maturation from cMoPs serves to maintain a stable pool of BM monocytes. Additionally, reduced CXCR4 expression on monocytes, upon their exit into the circulation, does not reflect its diminished role in monocyte biology. Specifically, CXCR4 regulates monocyte peripheral cellular activities by governing their circadian oscillations and pulmonary margination, which contributes toward lung injury and sepsis mortality. Together, our study demonstrates the multifaceted role of CXCR4 in defining BM monocyte heterogeneity and in regulating their function in peripheral tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20160800

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. CXCR4 defines heterogeneity among BM Ly6Chi monocytes. (A) BM Ly6Chi monocytes were gated accordingly (left) and subjected to t-SNE dimensional reduction (middle). Automatic clustering was performed using k-means, and clusters plotted into the t-SNE map (right). (B) Indicated markers are color mapped from blue (low expression) to red (high expression) into the t-SNE map. (C) Overlayed histograms of indicated markers constructed from data obtained from the k-means of cluster 1 (blue) and cluster 2 (red) that was generated from automated clustering. (A–C) Data are representative of one out of three experiments with at least n = 3 samples. (D–E) BM Ly6Chi monocytes in mice divided into CXCR4hi (blue) and CXCR4lo (red) subsets (D) with scanning electron microscopy images of mouse CXCR4hi (top) and CXCR4lo (bottom) subsets (E). Bars, 1 µm. Data are representative of one out of three experiments. (F) Gating strategy and division of human BM classical monocytes into CXCR4hi (blue) and CXCR4lo (red) subsets. Data are representative of one out of three experiments conducted with seven independent donors.
Figure 1. CXCR4 defines heterogeneity among BM Ly6Chi monocytes. (A) BM Ly6Chi monocytes were gated accordingly (left) and subjected to t-SNE dimensional reduction (middle). Automatic clustering was performed using k-means, and clusters plotted into the t-SNE map (right). (B) Indicated markers are color mapped from blue (low expression) to red (high expression) into the t-SNE map. (C) Overlayed histograms of indicated markers constructed from data obtained from the k-means of cluster 1 (blue) and cluster 2 (red) that was generated from automated clustering. (A–C) Data are representative of one out of three experiments with at least n = 3 samples. (D–E) BM Ly6Chi monocytes in mice divided into CXCR4hi (blue) and CXCR4lo (red) subsets (D) with scanning electron microscopy images of mouse CXCR4hi (top) and CXCR4lo (bottom) subsets (E). Bars, 1 µm. Data are representative of one out of three experiments. (F) Gating strategy and division of human BM classical monocytes into CXCR4hi (blue) and CXCR4lo (red) subsets. Data are representative of one out of three experiments conducted with seven independent donors.CC BY-NC-SA · PubMed Central
Figure 2. Transcriptomics reveal distinct expression signatures between the CXCR4hi and CXCR4lo Ly6Chi monocyte populations. (A–E) BM cMoP, CXCR4hi, and CXCR4lo Ly6Chi subsets and Ly6Clo monocytes were sorted from three individual mice according to the gating strategy (A), and then RNA extracted for NGS. (B) PCA of gene expression. (C) Volcano plots depicting the log2 fold change between cMoP and CXCR4hi subset (top) and CXCR4hi and CXCR4lo subset (bottom) versus the −log10 FDR. (D) Biofunction enrichment analysis of the top gene-ontology processes that are enriched when comparing cMoP versus CXCR4hi subset (top) and CXCR4hi versus CXCR4lo subset (bottom) using IPA. (E) Heat maps of gene expression (log2 CPM; top) and surface markers validated by flow cytometry (log2 MFI; bottom). Flow cytometry data are representative of one out of three experiments. (F) Frequency of proliferating cells among BM monocyte subsets determined by Fucci-474 mice in vivo. Numbers in histograms (top) represent percentage of proliferating cells. Results (bottom) are expressed as mean ± SD (n = 3) and representative of two independent experiments. ****, P < 0.0001 (one-way ANOVA). (G) Mouse monocyte subsets in cell cycle stages assessed through BrdU incorporation in vivo. Results are expressed as mean ± SD (n = 5) and representative of two independent experiments. ****, P < 0.0001 (one-way ANOVA). (H) Human BM cells were pulsed with 10 µM of BrdU in vitro and monocytes in the S phase (left) were found to be CXCR4hi, CD11blo, CD14lo, and HLA-DRhi (right). Results are representative of one out of four independent donors. (I) BM mouse monocytes subsets were assessed for their uptake of microspheres in vivo after 4 h through flow cytometry. Results are expressed as mean ± SD (n = 5) and representative of two independent experiments. **, P < 0.01 (one-way ANOVA).
Figure 2. Transcriptomics reveal distinct expression signatures between the CXCR4hi and CXCR4lo Ly6Chi monocyte populations. (A–E) BM cMoP, CXCR4hi, and CXCR4lo Ly6Chi subsets and Ly6Clo monocytes were sorted from three individual mice according to the gating strategy (A), and then RNA extracted for NGS. (B) PCA of gene expression. (C) Volcano plots depicting the log2 fold change between cMoP and CXCR4hi subset (top) and CXCR4hi and CXCR4lo subset (bottom) versus the −log10 FDR. (D) Biofunction enrichment analysis of the top gene-ontology processes that are enriched when comparing cMoP versus CXCR4hi subset (top) and CXCR4hi versus CXCR4lo subset (bottom) using IPA. (E) Heat maps of gene expression (log2 CPM; top) and surface markers validated by flow cytometry (log2 MFI; bottom). Flow cytometry data are representative of one out of three experiments. (F) Frequency of proliferating cells among BM monocyte subsets determined by Fucci-474 mice in vivo. Numbers in histograms (top) represent percentage of proliferating cells. Results (bottom) are expressed as mean ± SD (n = 3) and representative of two independent experiments. ****, P < 0.0001 (one-way ANOVA). (G) Mouse monocyte subsets in cell cycle stages assessed through BrdU incorporation in vivo. Results are expressed as mean ± SD (n = 5) and representative of two independent experiments. ****, P < 0.0001 (one-way ANOVA). (H) Human BM cells were pulsed with 10 µM of BrdU in vitro and monocytes in the S phase (left) were found to be CXCR4hi, CD11blo, CD14lo, and HLA-DRhi (right). Results are representative of one out of four independent donors. (I) BM mouse monocytes subsets were assessed for their uptake of microspheres in vivo after 4 h through flow cytometry. Results are expressed as mean ± SD (n = 5) and representative of two independent experiments. **, P < 0.01 (one-way ANOVA).CC BY-NC-SA · PubMed Central
Figure 3. Identification of a developmental relationship between subpopulations of BM Ly6Chi monocytes. (A) CMap analysis of cMoP, CXCR4hi subset, CXCR4lo subset, and Ly6Clo monocytes displaying their enrichment for Ly6Chi or Ly6Clo monocyte gene sets. (B) OLO reveals a computationally determined developmental order that starts with the cMoP and ends with the CXCR4lo subset as the most mature cell type. (A and B) Data were analyzed using transcriptomic data obtained from three individual mice. (C and D) BM Ly6Chi monocytes subjected to the Wanderlust algorithm using flow cytometry data of six parameters. Data are representative of one out of three independent experiments. (C) Events were plotted against the wanderlust parameter with low and high values representing early and late predicted events, respectively. Early and late events were next plotted for CXCR4 expression against CD11b, CCR2, and CX3CR1. (D) Wanderlust traces showing low CXCR4, CD31, and CD16/32 during the early trajectory (0–0.5), and an increase in CX3CR1, CCR2, and CD11b during the late trajectory (0.5–1). (E) Intrafemoral transfer of sorted CD45.1+ CXCR4hi subset into CD45.2 recipients. Blue dots represent transferred cells after 8 and 24 h. Results are representative of one out of five mice in three independent experiments. (F) FACS plots of BrdU+ (blue) and BrdU− (red) Ly6Chi monocytes after BrdU administration. Results are representative of one out of five independent mice. (G) Alteration in CXCR4 expression over time among BM Ly6Chi monocytes (left) and percentage of BrdU+ Ly6Chi monocytes in the blood (right) at various time points. ΔMFI was calculated by subtracting the CXCR4 MFI of BrdU− Ly6Chi monocytes from that of BrdU+ Ly6Chi monocytes (as described in Fig. S3). Results are expressed as mean ± SEM (n = 5) and representative of one out of two independent experiments. (H) Graph showing correlation between blood BrdU+ Ly6Chi monocytes and ΔMFI of CXCR4 in the BM. Each dot represents one data time point and significance was determined using a Pearson correlation test.
Figure 3. Identification of a developmental relationship between subpopulations of BM Ly6Chi monocytes. (A) CMap analysis of cMoP, CXCR4hi subset, CXCR4lo subset, and Ly6Clo monocytes displaying their enrichment for Ly6Chi or Ly6Clo monocyte gene sets. (B) OLO reveals a computationally determined developmental order that starts with the cMoP and ends with the CXCR4lo subset as the most mature cell type. (A and B) Data were analyzed using transcriptomic data obtained from three individual mice. (C and D) BM Ly6Chi monocytes subjected to the Wanderlust algorithm using flow cytometry data of six parameters. Data are representative of one out of three independent experiments. (C) Events were plotted against the wanderlust parameter with low and high values representing early and late predicted events, respectively. Early and late events were next plotted for CXCR4 expression against CD11b, CCR2, and CX3CR1. (D) Wanderlust traces showing low CXCR4, CD31, and CD16/32 during the early trajectory (0–0.5), and an increase in CX3CR1, CCR2, and CD11b during the late trajectory (0.5–1). (E) Intrafemoral transfer of sorted CD45.1+ CXCR4hi subset into CD45.2 recipients. Blue dots represent transferred cells after 8 and 24 h. Results are representative of one out of five mice in three independent experiments. (F) FACS plots of BrdU+ (blue) and BrdU− (red) Ly6Chi monocytes after BrdU administration. Results are representative of one out of five independent mice. (G) Alteration in CXCR4 expression over time among BM Ly6Chi monocytes (left) and percentage of BrdU+ Ly6Chi monocytes in the blood (right) at various time points. ΔMFI was calculated by subtracting the CXCR4 MFI of BrdU− Ly6Chi monocytes from that of BrdU+ Ly6Chi monocytes (as described in Fig. S3). Results are expressed as mean ± SEM (n = 5) and representative of one out of two independent experiments. (H) Graph showing correlation between blood BrdU+ Ly6Chi monocytes and ΔMFI of CXCR4 in the BM. Each dot represents one data time point and significance was determined using a Pearson correlation test.CC BY-NC-SA · PubMed Central
Figure 4. BM Ly6Chi monocyte subpopulations represent two distinct mobilizable pools. (A and B) BM monocyte subsets (cMoP, CXCR4hi and CXCR4lo Ly6Chi monocytes, and Ly6Clo monocytes) were quantified for their numbers (A) and their normalized CXCR4 MFI (B) at ZT5 and ZT13. Results are expressed as mean ± SD (n = 4–5) and representative of one out of three experiments. ns, not significant; *, P < 0.05; **, P < 0.01 (Student’s t test). (C) BM monocyte subset counts after LPS administration. Results expressed as mean ± SD (n = 5) and representative of one out of five independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (one-way ANOVA). (D) BrdU+ CXCR4hi and CXCR4lo subset counts after 2 h of LPS administration. Results expressed as mean ± SD (n = 5) and representative of one out of three independent experiments. ns, not significant; ***, P < 0.001 (Student’s t test). (E) CCR2 expression (left) and CCR2 MFI (arbitrary units; right) of CXCR4hi and CXCR4lo subsets. Results are expressed as mean ± SEM (n = 5). ****, P < 0.0001 (Student’s t test). (F) Chemotaxis assay of CXCR4hi and CXCR4lo subsets towards CCL2. Results expressed as mean ± SD (n = 5) and representative of two independent experiments. *, P < 0.05; **, P < 0.01 (two-way ANOVA).
Figure 4. BM Ly6Chi monocyte subpopulations represent two distinct mobilizable pools. (A and B) BM monocyte subsets (cMoP, CXCR4hi and CXCR4lo Ly6Chi monocytes, and Ly6Clo monocytes) were quantified for their numbers (A) and their normalized CXCR4 MFI (B) at ZT5 and ZT13. Results are expressed as mean ± SD (n = 4–5) and representative of one out of three experiments. ns, not significant; *, P < 0.05; **, P < 0.01 (Student’s t test). (C) BM monocyte subset counts after LPS administration. Results expressed as mean ± SD (n = 5) and representative of one out of five independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (one-way ANOVA). (D) BrdU+ CXCR4hi and CXCR4lo subset counts after 2 h of LPS administration. Results expressed as mean ± SD (n = 5) and representative of one out of three independent experiments. ns, not significant; ***, P < 0.001 (Student’s t test). (E) CCR2 expression (left) and CCR2 MFI (arbitrary units; right) of CXCR4hi and CXCR4lo subsets. Results are expressed as mean ± SEM (n = 5). ****, P < 0.0001 (Student’s t test). (F) Chemotaxis assay of CXCR4hi and CXCR4lo subsets towards CCL2. Results expressed as mean ± SD (n = 5) and representative of two independent experiments. *, P < 0.05; **, P < 0.01 (two-way ANOVA).CC BY-NC-SA · PubMed Central
Figure 5. CXCR4 regulates circadian rhythmic oscillations of monocytes. (A) Representative FACS plot of CXCR4 and CD11b expression by blood Ly6Chi monocytes (gating strategy in Fig. S4) of one out of four independent experiments. (B) Representative FACS plot depicting loss of CXCR4 expression in Lyz2creCxcr4fl mice (blue) as compared with Cxcr4fl controls (red) of one out of three independent experiments. (C) Comparison of blood leukocyte populations in RosamT/mG:Lyz2cre mice and RosamT/mG:Lyz2creCxcr4fl mice showing the percentage of Lyz2-cre mediated recombination (GFP+) at the Rosa26 locus (left) and normalized CXCR4 MFI (arbitrary units) of circulating leukocyte subsets (right). Results are expressed as mean ± SD (n = 4–5 mice per group). ns, not significant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001 (two-way ANOVA). (D and E) Blood Ly6Chi (D) and Ly6Clo (E) monocyte values of normalized CXCR4 MFI on Cxcr4fl control mice (left) and counts between Cxcr4fl control and Lyz2creCxcr4fl mice (right) were quantified at ZT5 and ZT13. Data are representative of one out of three experiments. Results are expressed as mean ± SD (n = 5 mice per group). ns, not significant; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (Student’s t test).
Figure 5. CXCR4 regulates circadian rhythmic oscillations of monocytes. (A) Representative FACS plot of CXCR4 and CD11b expression by blood Ly6Chi monocytes (gating strategy in Fig. S4) of one out of four independent experiments. (B) Representative FACS plot depicting loss of CXCR4 expression in Lyz2creCxcr4fl mice (blue) as compared with Cxcr4fl controls (red) of one out of three independent experiments. (C) Comparison of blood leukocyte populations in RosamT/mG:Lyz2cre mice and RosamT/mG:Lyz2creCxcr4fl mice showing the percentage of Lyz2-cre mediated recombination (GFP+) at the Rosa26 locus (left) and normalized CXCR4 MFI (arbitrary units) of circulating leukocyte subsets (right). Results are expressed as mean ± SD (n = 4–5 mice per group). ns, not significant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001 (two-way ANOVA). (D and E) Blood Ly6Chi (D) and Ly6Clo (E) monocyte values of normalized CXCR4 MFI on Cxcr4fl control mice (left) and counts between Cxcr4fl control and Lyz2creCxcr4fl mice (right) were quantified at ZT5 and ZT13. Data are representative of one out of three experiments. Results are expressed as mean ± SD (n = 5 mice per group). ns, not significant; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (Student’s t test).CC BY-NC-SA · PubMed Central
Figure 6. CXCR4 regulates homing of monocytes back to reservoirs. (A and B) Homing capacity (calculated as a ratio) of monocytes or indicated immune cells of WT and Lyz2creCxcr4fl (A) or Cxcr4WHIM (B) into the BM or spleen of their respective partners in parabiotic mice. Monocyte, neutrophil and T cell numbers were quantified in blood, BM and spleen before calculation of the respective homing ratios to normalize for unequal exchange in circulating leukocytes (n = 4–5). ns, not significant; *, P < 0.05; **, P < 0.01 (Student’s t test). Results are representative of one out of two independent experiments. (C) Percentage of nonhost cells present in blood of WT and Lyz2creCxcr4fl mice (left), and WT and Cxcr4WHIM parabiotic mice (right). Results are expressed as mean ± SD (n = 4–5) and representative of one out of two independent experiments. (D and E) Total number of donor (CD45.1+) monocytes with a Ly6Chi (left) or Ly6Clo (right) phenotype detected in blood (D) or BM (E) in recipient CD45.2+ mice that had been pretreated with or without AMD3100. Results are expressed as mean ± SD (n = 4) and representative of one out of three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (two-way ANOVA).
Figure 6. CXCR4 regulates homing of monocytes back to reservoirs. (A and B) Homing capacity (calculated as a ratio) of monocytes or indicated immune cells of WT and Lyz2creCxcr4fl (A) or Cxcr4WHIM (B) into the BM or spleen of their respective partners in parabiotic mice. Monocyte, neutrophil and T cell numbers were quantified in blood, BM and spleen before calculation of the respective homing ratios to normalize for unequal exchange in circulating leukocytes (n = 4–5). ns, not significant; *, P < 0.05; **, P < 0.01 (Student’s t test). Results are representative of one out of two independent experiments. (C) Percentage of nonhost cells present in blood of WT and Lyz2creCxcr4fl mice (left), and WT and Cxcr4WHIM parabiotic mice (right). Results are expressed as mean ± SD (n = 4–5) and representative of one out of two independent experiments. (D and E) Total number of donor (CD45.1+) monocytes with a Ly6Chi (left) or Ly6Clo (right) phenotype detected in blood (D) or BM (E) in recipient CD45.2+ mice that had been pretreated with or without AMD3100. Results are expressed as mean ± SD (n = 4) and representative of one out of three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (two-way ANOVA).CC BY-NC-SA · PubMed Central
Figure 7. Endotoxemia promotes monocyte retention in the pulmonary circulation. (A) Blood Ly6Chi (top) and Ly6Clo (bottom) monocyte counts after i.v. treatment with 10 ng LPS. Results are expressed as mean ± SEM (n = 4) and representative of one out of three independent experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001 (one-way ANOVA). (B) Illustration showing the intravascular labeling of leukocytes with anti-CD45 antibodies. (C) Representative flow cytometry plots showing the extravascular and intravascular localization of lung immune cells of one out of three independent experiments. (D and E) Quantification of Ly6Chi (left) and Ly6Clo (right) monocytes in blood (D) and lung tissues (E) from LPS-treated mice. Results are expressed as mean ± SEM (n = 4) and representative of one out of four experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (one-way ANOVA). (F) WT and Tlr4−/− chimeric mice were analyzed for Ly6Chi monocyte numbers after 1 h of LPS administration. Each data point represents one individual mouse and results are representative of two individual experiments. ns, not significant; **, P < 0.01 (one-way ANOVA).
Figure 7. Endotoxemia promotes monocyte retention in the pulmonary circulation. (A) Blood Ly6Chi (top) and Ly6Clo (bottom) monocyte counts after i.v. treatment with 10 ng LPS. Results are expressed as mean ± SEM (n = 4) and representative of one out of three independent experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001 (one-way ANOVA). (B) Illustration showing the intravascular labeling of leukocytes with anti-CD45 antibodies. (C) Representative flow cytometry plots showing the extravascular and intravascular localization of lung immune cells of one out of three independent experiments. (D and E) Quantification of Ly6Chi (left) and Ly6Clo (right) monocytes in blood (D) and lung tissues (E) from LPS-treated mice. Results are expressed as mean ± SEM (n = 4) and representative of one out of four experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (one-way ANOVA). (F) WT and Tlr4−/− chimeric mice were analyzed for Ly6Chi monocyte numbers after 1 h of LPS administration. Each data point represents one individual mouse and results are representative of two individual experiments. ns, not significant; **, P < 0.01 (one-way ANOVA).CC BY-NC-SA · PubMed Central
Figure 8. Monocytes marginate in the pulmonary vasculature. (A) A representative GFP+ monocyte (arrowhead) alters its morphology through pulmonary capillaries. Bar, 15 µm (time, h:mm:ss; green, CX3CR1+ cells; red, TRITC-dextran). Results are representative of one out of three independent experiments. (B and C) Monocyte mean velocity (B) and duration of adherence (C) after indicated treatments. Results are pooled from three independent experiments per treatment and are expressed as mean ± SEM. ns, not significant; **, P < 0.01; ***, P < 0.001; **** P < 0.0001 (one-way ANOVA). (D) LPS-induced fold-increase in lung Ly6Chi (left) and Ly6Clo (right) monocytes 1 h after treatment. Results expressed as mean ± SEM (n = 4–7). ns, not significant; *, P < 0.05; ***, P < 0.001 (one-way ANOVA). (E) Snapshots of GFP+ monocytes in the lung of a Cx3cr1gfp/+ reporter mouse, before (top) and after (bottom) i.v. administration of a Ly6B.2-PE antibody (4 µg). A representative GFP+ monocyte is depicted migrating through pulmonary capillaries (white track), becomes PE+ after antibody administration Bar, 15 µm (time, h:mm:ss; green, CX3CR1+ cells; red, Ly6B.2+ cells; blue, Evans blue). Results are representative of one out of three independent experiments. (F) FACS plots of lungs from Cx3cr1gfp/+ mice i.v. injected with Ly6B.2-PE. Ly6Chi (red), Ly6Clo monocytes (orange), and neutrophils (green) were plotted in relation to Ly6B.2 expression. Results are representative of one out of three independent experiments.
Figure 8. Monocytes marginate in the pulmonary vasculature. (A) A representative GFP+ monocyte (arrowhead) alters its morphology through pulmonary capillaries. Bar, 15 µm (time, h:mm:ss; green, CX3CR1+ cells; red, TRITC-dextran). Results are representative of one out of three independent experiments. (B and C) Monocyte mean velocity (B) and duration of adherence (C) after indicated treatments. Results are pooled from three independent experiments per treatment and are expressed as mean ± SEM. ns, not significant; **, P < 0.01; ***, P < 0.001; **** P < 0.0001 (one-way ANOVA). (D) LPS-induced fold-increase in lung Ly6Chi (left) and Ly6Clo (right) monocytes 1 h after treatment. Results expressed as mean ± SEM (n = 4–7). ns, not significant; *, P < 0.05; ***, P < 0.001 (one-way ANOVA). (E) Snapshots of GFP+ monocytes in the lung of a Cx3cr1gfp/+ reporter mouse, before (top) and after (bottom) i.v. administration of a Ly6B.2-PE antibody (4 µg). A representative GFP+ monocyte is depicted migrating through pulmonary capillaries (white track), becomes PE+ after antibody administration Bar, 15 µm (time, h:mm:ss; green, CX3CR1+ cells; red, Ly6B.2+ cells; blue, Evans blue). Results are representative of one out of three independent experiments. (F) FACS plots of lungs from Cx3cr1gfp/+ mice i.v. injected with Ly6B.2-PE. Ly6Chi (red), Ly6Clo monocytes (orange), and neutrophils (green) were plotted in relation to Ly6B.2 expression. Results are representative of one out of three independent experiments.CC BY-NC-SA · PubMed Central
Figure 9. CXCR4 regulates pulmonary monocyte margination and predisposition to injury. (A) Schematic of the lung efflux assay. (B) Monocyte numbers released from the lung vasculature after indicated treatments. Results expressed as mean (n = 5–7 per group) and representative of one out of three independent experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (one-way ANOVA). (C and D) Frequency of blood (C) and pulmonary release (D) of CD14+CD16− classical monocytes in humanized mice at baseline and 2 h after AMD3100 treatment (n = 8–11). Results are representative of one out of two independent experiments. **, P < 0.01 (Student’s t test). (E) Net monocyte release from the lungs of two individual nonhuman primates (Macaca fascicularis) over a 4-h observation period. (F–H) Lyz2creCxcr4fl mice were compared with Cxcr4fl control mice for lung vascular leakage during acute lung injury (F; n = 5; **, P < 0.01, Student’s t test) or fold-increase accumulation of lung Ly6Chi (left) and Ly6Clo (right) monocytes (G; n = 3–5; ***, P < 0.001, Student’s t test) and their mortality using the Kaplan-Meier survival curve (H; n = 10; ****, P < 0.0001, Mantel-Cox) in the CLP sepsis model. Results are representative of one out of three independent experiments.
Figure 9. CXCR4 regulates pulmonary monocyte margination and predisposition to injury. (A) Schematic of the lung efflux assay. (B) Monocyte numbers released from the lung vasculature after indicated treatments. Results expressed as mean (n = 5–7 per group) and representative of one out of three independent experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (one-way ANOVA). (C and D) Frequency of blood (C) and pulmonary release (D) of CD14+CD16− classical monocytes in humanized mice at baseline and 2 h after AMD3100 treatment (n = 8–11). Results are representative of one out of two independent experiments. **, P < 0.01 (Student’s t test). (E) Net monocyte release from the lungs of two individual nonhuman primates (Macaca fascicularis) over a 4-h observation period. (F–H) Lyz2creCxcr4fl mice were compared with Cxcr4fl control mice for lung vascular leakage during acute lung injury (F; n = 5; **, P < 0.01, Student’s t test) or fold-increase accumulation of lung Ly6Chi (left) and Ly6Clo (right) monocytes (G; n = 3–5; ***, P < 0.001, Student’s t test) and their mortality using the Kaplan-Meier survival curve (H; n = 10; ****, P < 0.0001, Mantel-Cox) in the CLP sepsis model. Results are representative of one out of three independent experiments.CC BY-NC-SA · PubMed Central
Figure 10. CXCR4 identifies a TpMo population in the BM and mediates monocyte cellular responses in peripheral tissues. (top) Monocytes arise from cMoPs and undergo a developmental pathway that ends with Ly6Clo monocytes as the terminally differentiated form of monocytes. In this study, we propose that cMoP-differentiated Ly6Chi monocytes undergo a developmental transition, which involves a transitional premonocyte (TpMo) stage, before giving rise to mature Ly6Chi monocytes. TpMos are identified based on their CXCR4hi expression compared with mature Ly6Chi monocytes that are CXCR4lo. Furthermore, TpMos can be distinguished from cMoPs based on their negative expression for c-kit. Functionally, TpMos are immobilized in the BM to serve as an immediate precursor for the active pool of mature CXCR4lo Ly6Chi monocytes. (Bottom) Upon entering the circulation, CXCR4 plays a significant role in monocyte margination in the pulmonary vasculature. Exposure to subclinical LPS doses triggers increased pulmonary monocyte margination, leading to a transient state of monocytopenia that can be reversed with CXCR4 inhibition using AMD3100. Disruption in CXCR4 signaling also attenuated lung injury and prevented sepsis mortality.
Figure 10. CXCR4 identifies a TpMo population in the BM and mediates monocyte cellular responses in peripheral tissues. (top) Monocytes arise from cMoPs and undergo a developmental pathway that ends with Ly6Clo monocytes as the terminally differentiated form of monocytes. In this study, we propose that cMoP-differentiated Ly6Chi monocytes undergo a developmental transition, which involves a transitional premonocyte (TpMo) stage, before giving rise to mature Ly6Chi monocytes. TpMos are identified based on their CXCR4hi expression compared with mature Ly6Chi monocytes that are CXCR4lo. Furthermore, TpMos can be distinguished from cMoPs based on their negative expression for c-kit. Functionally, TpMos are immobilized in the BM to serve as an immediate precursor for the active pool of mature CXCR4lo Ly6Chi monocytes. (Bottom) Upon entering the circulation, CXCR4 plays a significant role in monocyte margination in the pulmonary vasculature. Exposure to subclinical LPS doses triggers increased pulmonary monocyte margination, leading to a transient state of monocytopenia that can be reversed with CXCR4 inhibition using AMD3100. Disruption in CXCR4 signaling also attenuated lung injury and prevented sepsis mortality.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 142

Metadata

Authors
Chong, S. Z., Evrard, M., Devi, S., Chen, J., Lim, J. Y., See, P., Zhang, Y., Adrover, J. M., Lee, B., Tan, L., Li, J. L. Y., Liong, K. H., Phua, C., Balachander, A., Boey, A., Liebl, D., Tan, S. M., Chan, J. K. Y., Balabanian, K., Harris, J. E., Bianchini, M., Weber, C., Duchene, J., Lum, J., Poidinger, M., Chen, Q., Rénia, L., Wang, C.-I., Larbi, A., Randolph, G. J., Weninger, W., Looney, M. R., Krummel, M. F., Biswas, S. K., Ginhoux, F., Hidalgo, A., Bachelerie, F., & Ng, L. G.
Affiliations
  • Agency for Science, Technology and Research (SG)
  • Spanish National Centre for Cardiovascular Research (ES)
  • Nanyang Technological University (SG)
  • National University of Singapore (SG)
  • Université Paris-Sud (FR)
  • University of Massachusetts Chan Medical School (US)
  • Ludwig-Maximilians-Universität München (DE)
  • Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich 80336, Germany 11
  • Washington University in St. Louis (US)
  • Centenary Institute (AU)
  • University of California, San Francisco (US)
Corresponding author
  • Chong, Shu Zhen
  • Ng, Lai Guan
Venue
Journal of Experimental Medicine
Published
2016-10-10
Volume
213
Issue
11
Pages
2293-2314
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2530903079
Cited by
142
References
85
Citations by year
2026: 10 · 2025: 12 · 2024: 10 · 2023: 17 · 2022: 15 · 2021: 20 · 2020: 18 · 2019: 19 · 2018: 11 · 2017: 9
FWCI
7.00
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion, cc-by-nc-sa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
Funders
  • A*STAR
  • Deutsche Forschungsgemeinschaft (SFB1123-A1/Z1)
Topics
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
CXCR4, monocytes, bone marrow-derived monocytes, Ly6Chi monocytes, monocyte heterogeneity, monocyte maturation, monocyte mobilization, circadian oscillations, lung injury, sepsis, monocyte subpopulations
MeSH terms
Animals, Antigens, Ly, Bone Marrow Cells, Cell Differentiation, Circadian Rhythm, Endotoxins, Female, Lung, Mice, Inbred C57BL, Monocytes, Receptors, CXCR4, Gene Expression Profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.